Hartford Investment Management Co. Sells 144 Shares of Humana Inc. (NYSE:HUM)

Hartford Investment Management Co. lowered its stake in shares of Humana Inc. (NYSE:HUM) by 1.9% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 7,436 shares of the insurance provider’s stock after selling 144 shares during the period. Hartford Investment Management Co.’s holdings in Humana were worth $1,887,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Atlas Brown Inc. lifted its position in Humana by 0.6% during the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after purchasing an additional 38 shares during the period. Moors & Cabot Inc. raised its stake in Humana by 2.5% during the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after buying an additional 40 shares during the last quarter. Mather Group LLC. lifted its holdings in shares of Humana by 21.0% during the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after buying an additional 41 shares during the period. OLD National Bancorp IN boosted its stake in shares of Humana by 1.8% in the 3rd quarter. OLD National Bancorp IN now owns 2,613 shares of the insurance provider’s stock worth $828,000 after buying an additional 45 shares during the last quarter. Finally, Your Advocates Ltd. LLP grew its holdings in shares of Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after acquiring an additional 45 shares during the period. Institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on HUM. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and increased their target price for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Barclays increased their price objective on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday. Cantor Fitzgerald restated a “neutral” rating and set a $290.00 target price on shares of Humana in a research report on Wednesday. Truist Financial upped their target price on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Finally, Morgan Stanley dropped their price target on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Nineteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $293.05.

Humana Stock Down 2.7 %

NYSE HUM opened at $252.92 on Friday. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market cap of $30.45 billion, a PE ratio of 22.40, a P/E/G ratio of 2.11 and a beta of 0.56. The stock’s 50 day moving average is $272.44 and its 200 day moving average is $295.47.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%. Research analysts predict that Humana Inc. will post 16.11 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.32% of the company’s stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.